Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?
Author(s) -
Steven G. Waguespack,
Sanjit O. Tewari,
Naifa L. Busaidy,
Mark Zafereo
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.21.00467
Subject(s) - thyroid carcinoma , radioactive iodine , medicine , trk receptor , oncology , disease , radioiodine therapy , cancer research , thyroid , receptor , neurotrophin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom